Pulmonx Corporation provided revenue guidance for the full year 2024 . The company expects revenue for the full year 2024 to be in the range of $81 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -0.68% | -10.16% | -43.14% |
May. 01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
May. 01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.14% | 281M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+6.22% | 6.61B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.14% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Full Year 2024